News & Perspective

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 26, 2007

Oct 26, 2007

THE PANDEMIC VACCINE PUZZLE Part 2: Vaccine production capacity falls far short

Editor's note: This is the second in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Apr 13, 2007

Apr 13, 2007

Produce firm names winners of E coli research grants

(CIDRAP News) – A scientific advisory panel assembled by Fresh Express, a California produce company, has selected nine research teams to receive awards up to $250,000 each to study how to keep Escherichia coli O157:H7 from contaminating fresh produce.

Apr 12, 2007

Apr 12, 2007

Insect-cell-based flu vaccine looks good in clinical trial

(CIDRAP News) – An influenza vaccine grown in insect cells instead of chicken eggs proved safe and yielded a good immune response in a trial in healthy adults, possibly signaling a significant advance in flu vaccine production technology, according to a report published this week in the Journal of the American Medical Association (JAMA).

Jan 19, 2007

Jan 19, 2007

California produce firm to fund E coli research

(CIDRAP News) – Fresh Express, a California company that produces bagged salads and other produce products, announced this week it would provide up to $2 million for research on how to keep Escherichia coli O157:H7 out of fresh produce.

A scientific advisory panel assembled by the company has chosen five research priorities and will evaluate research proposals and disseminate findings, the company said in a Jan 17 news release.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»